Progression of eye disease over 15 years in a patient with mucopolysaccharidosis type VI on enzyme replacement therapy

BMJ Case Rep. 2021 Feb 10;14(2):e238544. doi: 10.1136/bcr-2020-238544.
No abstract available

Keywords: metabolic disorders; ophthalmology.

Publication types

  • Case Reports

MeSH terms

  • Enzyme Replacement Therapy
  • Eye Diseases*
  • Humans
  • Mucopolysaccharidosis VI* / drug therapy
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins